IL-33 and IL-13 synergistically induce M2 macrophage polarization, and anti-IL-33 antibody treatment and ST2 deficiency can attenuate bleomycin-mediated pulmonary inflammation and fibrosis [140]. Here, IL33 is linked to fibrosis.